NCT00392587View on ClinicalTrials.gov

A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 31, 2006

Conditions

Pulmonary Disease, Chronic ObstructiveChronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

GW856553

Trial Locations (3)

14050

GSK Investigational Site, Berlin

22927

GSK Investigational Site, Großhansdorf

30625

GSK Investigational Site, Hanover

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY